Archived
Antiemetics: ASCO Guideline Update
- Completion Date
- July 2020
- Topic
- Chemotherapy-induced nausea and vomiting
- Type
- Clinical Practice Guideline
- Developing Organization:
- ASCO
- Endorsing Organization:
- COG
Related Guidance
Treatment of breakthrough and prevention of refractory chemotherapy-induced nausea and vomiting in pediatric cancer patients: Clinical practice guideline update
September 2023 Active
Developing Organization: POGO
Learn more
Prevention of acute and delayed phase chemotherapy-induced nausea and vomiting: a clinical practice guideline
October 2022 Active
Developing Organization: POGO
Learn more
Classification of the acute emetogenicity of chemotherapy in pediatric patients:Update
January 2019 Update in progress
Developing Organization: POGO
Learn more
Antiemetics: ASCO Guideline Update
July 2020 Archived
Developing Organization: ASCO
Learn more
Nausées-vomissements induits par les traitements anticancéreux (NVITAC) en onco-hématologie pédiatrique : recommandations 2022 du Comité soins de support de la SFCE. Antineoplastic drug-induced nausea and vomiting in pediatric onco-hematology: 2022: Guidelines from the supportive care committee of the French Society of Childhood Cancer (SFCE)
November 2022 Active
Developing Organization: French Society of Childhood Cancer (SFCE)
Learn more
Prevention and treatment of anticipatory chemotherapy-induced nausea and vomiting in pediatric cancer patients and hematopoietic stem cell recipients: Clinical practice guideline update
January 2021 Active
Developing Organization: POGO
Learn more
